Oct 01, 2021 · Neutropenia due to chemotherapy ICD-10-CM D70.1 is grouped within Diagnostic Related Group(s) (MS-DRG v 39.0): 808 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with mcc
Oct 01, 2019 · 4.6/5 (374 Views . 41 Votes) D70. 3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM D70. 3 became effective on October 1, 2019. Click to see full answer.
Oct 01, 2021 · D70.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D70.3 became effective on October 1, 2021. This is the American ICD-10-CM version of D70.3 - other international versions of ICD-10 D70.3 may differ.
ICD-10-CM Diagnosis Code D70. Neutropenia. neutropenic splenomegaly (D73.81); transient neonatal neutropenia (P61.5); agranulocytosis; decreased absolute neurophile count (ANC); code for any associated:; fever (R50.81); mucositis (J34.81, K12.3-, K92.81, N76.81) ICD-10-CM Diagnosis Code D70. D70 Neutropenia.
ICD-10 Codes for Long-term Therapies | |
---|---|
Code | Long-term (current) use of |
Z79.84 | oral hypoglycemic drugs |
Z79.891 | opiate analgesic |
Z79.899 | other drug therapy |
Assign first the appropriate code from category T86.-, Complications of transplanted organs and tissue, followed by code C80.2, Malignant neoplasm associated with transplanted organ. Use an additional code for the specific malignancy.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only , the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present .
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.
Code C80.1, Malignant ( primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy. This code should rarely be used in the inpatient setting.
When a primary malignancy has been excised but further treatment, such as an additional surgery for the malignancy, radiation therapy or chemotherapy is directed to that site, the primary malignancy code should be used until treatment is completed.